LinkOPH

Peter Barry, FRCS , an outstanding member of the European ophthalmology community and lead author of the pivotal ESCRS study on endophthalmitis prevention, died May 26 after a short illness — a sudden, unexpected loss that leaves his friends and colleagues astounded and bereft.Barry did his ophthalmology residency at Moorfields Eye Hospital in London and completed his training with a retina fellowship in the U.S. For many years he was head of the Department of Ophthalmology at St. Vincent’s University Hospital and senior retinal surgeon at the Royal Victorian Eye (Read more...)

Moria announced the release of a single-use donor vacuum guarded punch for endothelial graft preparation.The device has a 350-µm guarded blade designed to score Descemet’s membrane with one press, according to a press release. The blade makes a non-penetrating trephination with a 360° stromal incision without a hinge.

Read more →

LASIK is the most common refractive surgery performed worldwide. Some patients, however, are not suitable candidates for excimer laser refractive surgery due to high refractive error, issues with pupil diameter, corneal thickness or questionable cornea…

Read more →

MILAN — Long-term experience with light technologies shows that they are effective in treating meibomian gland dysfunction and dry eye disease. “Light is used as a therapy in many branches of medicine, but ophthalmologists are slow to adopt it in spite of numerous studies,” Rolando Toyos, MD, said at the OSN Italy meeting.

Read more →

DUBLIN–(BUSINESS WIRE)–Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced that all 421 subjects treated with the Presbia Flexivue Microlens™ as part of its U.S. Food and Drug Administration (FDA) pivotal study completed their 6-month post-operative visits, one step closer to making the submission of its final PMA module to the FDA in approximately 18 months. The Presbia Flexivue Microlens is a revolutionary optical lens implant for treati

Read more →